My Health News » Medical News Today - Cancer/Oncology News

Feeds

356293 items (356293 unread) in 46 feeds

World Health Organization (804 unread)

• WHO news (383 unread)
• Disease Outbreak News (421 unread)

Media (277420 unread)

• Reuters Health eLine (11469 unread)
• CNN Health (4228 unread)
• NPR Health and Science (5588 unread)
• ABC News: Health (9089 unread)
• CBSnews.com: Health News (10855 unread)
• BBC Health News (8289 unread)
• CBC Health and Science News (8084 unread)
• Australia ABC News: Health (16295 unread)
• China Xinghua Health News (8874 unread)
• New York Times: Health (14775 unread)
• USATODAY.com Health - Top Stories (6061 unread)
• The Seattle Times: Health (6440 unread)
• International Herald Tribune: Health and Science (6409 unread)
• HeraldToday.com: Health (2842 unread)
• WebMD Health Headlines (7709 unread)
• MedicineNet Daily News (16091 unread)
• Medical News Today (86093 unread)
• iVillage Health (956 unread)
• Topix.net - Health (7091 unread)
• Newsvine - health (40182 unread)

Bird Flu (5943 unread)

• MSNBC.com: Bird Flu (171 unread)
• Topix.net - Bird Flu (3616 unread)
• Medical News Today - Bird Flu/Avian Flu (751 unread)
• MedicineNet Cold and Flu General (1405 unread)

Diabetes (13122 unread)

• Topix.net - Diabetes (6819 unread)
• Medical News Today - Diabetes (4570 unread)
• MedicineNet Diabetes General (1733 unread)

Cholesterol (5064 unread)

• Topix.net - Cholesterol (2201 unread)
• Medical News Today - Cholesterol (707 unread)
• MedicineNet Cholesterol General (2156 unread)

Cancer (26753 unread)

• MSNBC.com: Cancer (994 unread)
• Topix.net - Cancer (6677 unread)
• Medical News Today - Breast Cancer News (3479 unread)
• Medical News Today - Cancer/Oncology News (12074 unread)
• MedicineNet Cancer General (3529 unread)

HIV (14497 unread)

• Topix.net - HIV/AIDS (6195 unread)
• Medical News Today - HIV/AIDS News (7777 unread)
• MedicineNet HIV General (525 unread)

Women (9797 unread)

• MSNBC.com: Women's Health (630 unread)
• Medical News Today - OBGYN News (6558 unread)
• MedicineNet Womens Health General (2609 unread)

Men (2893 unread)

• MSNBC.com: Men's Health (288 unread)
• Medical News Today - Men's health News (1244 unread)
• MedicineNet Mens Health General (1361 unread)

Medical News Today - Cancer/Oncology News (30 unread)

• Important Breakthrough In Origins Of Aggressive Breast Cancer

  Posted: September 3rd, 2010, 10:00am CDT

  Researchers have made a major breakthrough in finding out how aggressive cancers originate, raising hope of novel targeted therapies for future breast cancer patients, according to a study published in the peer-reviewed journal Cell Stem Cell...

• Need For Cancer Information And Support Expected To Double, UK

  Posted: September 3rd, 2010, 9:00am CDT

  Macmillan Cancer Support and Boots UK today officially launched a groundbreaking new three-year partnership, which aims to help provide the two million people living with cancer, and their family and friends, increased access to the information and support they need - when they need it, where they need it...

• Celsion Receives SBIR Grant To Expand Its Technology Platform

  Posted: September 3rd, 2010, 7:00am CDT

  Celsion Corporation (Nasdaq: CLSN), a biotechnology drug development company, announced that it has been awarded a competitive Phase I Small Business Innovation and Research (SBIR) grant from the National Institutes of Health (NIH), to support the proposal, "New Thermal Sensitive Carboplatin Liposomes for Cancer"...

• Cancer Drug Model Could Be A Potential Treatment For Alzheimer's - Alzheimer's Society Comment

  Posted: September 3rd, 2010, 7:00am CDT

  Treatments modelled on the cancer drug Gleevec could potentially prevent the formation of amyloid plaques - one of the major hallmarks of Alzheimer's disease according to a study. Treatments modelled on the cancer drug Gleevec could potentially prevent the formation of amyloid plaques - one of the major hallmarks of Alzheimer's disease according to a study published in the journal Nature...

• Drug Discovery Tools To Fight Cancer, Blindness To Be Discussed At UB Symposium

  Posted: September 3rd, 2010, 7:00am CDT

  Twenty-first-century pharmaceutical breakthroughs require 21st-century drug discovery tools, such as computational or in silico molecular design and high-throughput screening of effective, new compounds. That's the theme of a University at Buffalo symposium to be held Sept...

• Imec European Collaborative Research To Develop Lab-on-chip System For Cheap And Fast Cancer Diagnosis

  Posted: September 3rd, 2010, 5:00am CDT

  Today, at the Engineering in Medicine and Biology Conference (EMBC) in Buenos Aires (Argentina), imec and its project partners have announced the launch of the European Seventh Framework Project MIRACLE. The MIRACLE project aims to develop an operational lab-on-chip for the isolation and detection of circulating and disseminated tumor cells (CTCs and DTCs) in blood...

• Near Infrared Light May Open New Frontier In Fighting Cancer, Tay-Sachs

  Posted: September 3rd, 2010, 5:00am CDT

  A "game-changing" technique using near infrared light enables scientists to look deeper into the guts of cells, potentially opening up a new frontier in the fights against cancer and many other diseases. University of Central Florida chemists, led by Professor Kevin Belfield, used near infrared light and fluorescent dye to take pictures of cells and tumors deep within tissue...

• Connection Between Light At Night (LAN) And Cancer Revealed

  Posted: September 3rd, 2010, 4:00am CDT

  A new study from the Center for Interdisciplinary Chronobiological Research at the University of Haifa has found an additional link between Light At Night (LAN) and cancer. This research joins a series of earlier studies carried out at the University of Haifa that also established the correlation...

• Afferent Pharmaceuticals Presents Data Supporting Use Of P2X3 Antagonists In Reducing Bone Cancer Pain

  Posted: September 3rd, 2010, 4:00am CDT

  Afferent Pharmaceuticals, a clinical-stage biopharmaceutical company developing first-in-class, small molecules that target P2X3 receptors, announced preclinical in vivo results demonstrating that an investigational P2X3 receptor antagonist significantly prevented and reversed bone cancer pain behavior in comparison to vehicle controls...

• Asuragen's Clinical Laboratory Launches KRAS And BRAF Mutation Testing

  Posted: September 3rd, 2010, 4:00am CDT

  Asuragen, Inc., a leader in molecular diagnostics and nucleic acid-based pharmacogenomics services, announced that it has launched KRAS and BRAF mutational testing services in its CAP-accredited CLIA laboratory...

• Common Osteoporosis Drug Linked To Higher Risk Of Oesophageal Cancer

  Posted: September 3rd, 2010, 4:00am CDT

  A new UK study that followed a large number of people found that those who took 10 or more prescriptions for oral bisphosphonates, a group of drugs commonly used to treat the bone disease osteoporosis, were at higher risk of developing oesophageal cancer...

• Molecular Imaging's Benefits In The Evaluation And Successful Treatment Planning For A Wide Spectrum Of Diseases

  Posted: September 3rd, 2010, 3:00am CDT

  A series of studies published in the September Journal of Nuclear Medicine (JNM) show that molecular imaging plays a critical role in the evaluation and treatment planning for a broad spectrum of cancers, including thyroid cancer and lymphoma...

• Chromosomal Rearrangement, Gene Copy Number Methods Featured In Cold Spring Harbor Protocols

  Posted: September 3rd, 2010, 3:00am CDT

  A cell devotes a significant amount of effort to maintaining the stability of its genome, preventing the sorts of chromosomal rearrangements characteristic of many cancers. Assays that measure the rate of gross chromosomal rearrangements (GCRs) are needed in order to understand the individual genes and the different pathways that suppress genomic instability...

• Cancer Patients Pay The Price To Keep Warm , UK

  Posted: September 3rd, 2010, 3:00am CDT

  With temperatures set to plummet below freezing across the UK this week, leading cancer charity Macmillan Cancer Support is warning that keeping warm will be even harder for cancer patients undergoing treatment, as they are already twice as likely to fall into fuel poverty as the general population 1 ...

• Macmillan's Response To NICE Decision On Liver Cancer Drug

  Posted: September 3rd, 2010, 3:00am CDT

  Responding to the decision by the National Institute for Health and Clinical Excellence (NICE) not to recommend sorafenib (Nexavar®) as a treatment for advanced liver cancer, Mike Hobday, Head of Campaigns at Macmillan Cancer Support, said: 'We are extremely disappointed that NICE has decided not to recommend sorafenib as a treatment for people with advanced liver cancer...

• Novel Nanotechnology Collaboration Leads To Breakthrough In Cancer Research

  Posted: September 3rd, 2010, 2:00am CDT

  One of the most difficult aspects of working at the nanoscale is actually seeing the object being worked on. Biological structures like viruses, which are smaller than the wavelength of light, are invisible to standard optical microscopes and difficult to capture in their native form with other imaging techniques...

• RNAi Screening Used For The First Time To Study Ewing's Sarcoma

  Posted: September 3rd, 2010, 2:00am CDT

  The first study of Ewing's sarcoma that screened hundreds of genes based on how they affect cell growth has identified two potential anti-cancer drug targets, according to a scientific paper by the Translational Genomics Research Institute (TGen) published in the journal Molecular Cancer...

• Immune System Finding May Lead To New Ways To Detect, Diagnose And Treat Cancer And Other Diseases

  Posted: September 3rd, 2010, 2:00am CDT

  When it comes to the mechanics of the human immune system, we are all more alike than previously thought, according to a new study by scientists at Fred Hutchinson Cancer Research Center. This finding has significant implications for developing new ways to detect, diagnose and treat cancer and diseases of the immune system, according to Harlan Robins, Ph.D...

• News From The Journal Of Clinical Investigation: Sept. 1, 2010

  Posted: September 3rd, 2010, 2:00am CDT

  INFECTIOUS DISEASE: Modified adenovirus malaria vaccine works a treat in mice Malaria kills more than 1 million individuals each year. Despite intensive research, there is still no malaria vaccine approved for use. A team of researchers, led by Moriya Tsuji, at the Aaron Diamond AIDS Research Center, New York, has now designed a new vaccine that provides protection from malaria in mice...

• Macmillan Responds To The New Energy Bill Announced In The Queen's Speech, UK

  Posted: September 2nd, 2010, 8:00am CDT

  Responding to the new energy bill announced in the Queen's Speech, Mike Hobday, Head of Campaigns at Macmillan Cancer Support said: 'Whilst the mandatory support from energy companies will help some vulnerable people struggling with their fuel bills, it is vital that cancer patients are not left out in the cold...

• Diabetes 2 Drug Metformin May Protect Against Lung Cancer In Smokers

  Posted: September 2nd, 2010, 8:00am CDT

  Two studies reveal that smokers may have a significantly lower risk of developing lung cancer and colorectal cancer with the drug metformin, which is commonly prescribed for diabetes type 2 treatment, the medical journal Cancer Prevention Research informs...

• Today's Opinions: Pawlenty's Order Against The Health Overhaul, Repealing The Health Law And More About Health Care Costs

  Posted: September 2nd, 2010, 7:00am CDT

  Pawlenty's Order Pure Politicking The Bemidji (Minn.) Pioneer The move can be explained in no other way than in being a totally partisan decision, intended to shore up his conservatism in what will be a 2012 battle of who is more conservative to wear the Republican mantle for president (9/1)...

• Trial To Test Experimental Drug For Advanced Pancreatic Cancer

  Posted: September 2nd, 2010, 6:00am CDT

  Cancer Research UK's Drug Development Office has launched a clinical trial* to test an experimental drug in patients with advanced (Stage IV) pancreatic cancer - one of the most difficult cancers to treat. Around 60 patients with advanced pancreatic cancer will be recruited for the first Phase I/IIclinical trial of a drug called MK-0752** in this disease...

• New Evidence That Fat Cells Are Not Just Dormant Storage Depots For Calories

  Posted: September 2nd, 2010, 6:00am CDT

  Scientists are reporting new evidence that the fat tissue in those spare tires and lower belly pooches - far from being a dormant storage depot for surplus calories - is an active organ that sends chemical signals to other parts of the body, perhaps increasing the risk of heart attacks, cancer, and other diseases...

• Cancer Center To Be The First In Europe To Install A CyberKnife VSI System, The Latest Generation Of The CyberKnife System

  Posted: September 2nd, 2010, 5:00am CDT

  Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced that the first CyberKnife VSI System to be installed in Europe was placed at the Leon-Berard Cancer Multidisciplinary Center (CLB) in Lyon, France. The CyberKnife VSI System is the newest addition to the CyberKnife product family...

• Agensys, An Affiliate Of Astellas, Announces Initiation Of Phase I Clinical Trial Of AGS-16M8F For Renal Cancer

  Posted: September 2nd, 2010, 4:00am CDT

  Agensys, Inc., an affiliate of Tokyo-based Astellas Pharma Inc., announced that they have initiated a Phase I clinical trial of AGS-16M8F an antibody-drug conjugate (ADC) that is being developed for the treatment of metastatic renal cancer. An ADC uses the specific binding properties of an antibody to target a toxin in tumor cells, resulting in selective tumor cell killing...

• Open House At Gulf Coast Cancer Treatment Center Introduces Elekta Synergy® To Community

  Posted: September 2nd, 2010, 4:00am CDT

  Gulf Coast Cancer Treatment Center, the area's only American College of Radiology-accredited radiation oncology center, introduces the Elekta Synergy system. The new technology will be showcased at the center's Open House on Thursday, September 16, 2010 from 1 p.m. to 7 p.m. Gulf Coast Cancer Treatment Center (GCCTC) is located at 2100 State Avenue in Panama City. Radiation oncologists Dr. D.B...

• Radiation Oncology Services Of America, Inc. To Work With Washington University On Quality Assurance Initiative

  Posted: September 2nd, 2010, 4:00am CDT

  Radiation Oncology Services of America, Inc. (ROSA), a subsidiary of Ambulatory Services of America, Inc. (ASA), announced that it has entered into an agreement with the Department of Radiation Oncology at the Washington University in St. Louis School of Medicine to embark on a Cooperative Quality Assurance Project...

• Michael Douglas Says He Has Stage Four Throat Cancer

  Posted: September 2nd, 2010, 4:00am CDT

  Michael Douglas told a US television audience on Tuesday night that he has been diagnosed with and is receiving treatment for stage four throat cancer. Speaking on David Letterman's "Late Show" to promote the release of his new film "Wall Street: Money Never Sleeps", the 65- year old American actor and producer said his doctors had told him he has an 80 per cent chance of survival...

• European Collaborative Research To Develop Lab-on-chip System For Cheap And Fast Cancer Diagnosis

  Posted: September 2nd, 2010, 3:00am CDT

  Detection of circulating and disseminated tumor cells in blood is a promising methodology to diagnose cancer dissemination or to follow up cancer patients during therapy. Today, the detection analyses of these cells are performed in medical laboratories requiring labor intensive, expensive and time-consuming sample processing and cell isolation steps...